ChEVAS for Abdominal Aortic Aneurysm
(ChEVAS One Trial)
Trial Summary
What is the purpose of this trial?
Prospective, multi-center, non-randomized study with consecutive, eligible subject enrollment at each site, for the evaluation of the ChEVAS System for Endovascular Repair of Complex Abdominal Aortic Aneurysms.
Do I need to stop my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, if you have a known allergy or contraindication to any device material, contrast, or anticoagulants, you may not be eligible to participate.
What data supports the effectiveness of the ChEVAS treatment for Abdominal Aortic Aneurysm?
Is the ChEVAS system generally safe for humans?
Research on the ChEVAS system, used for treating abdominal aortic aneurysms, shows it has been evaluated in several studies, including long-term follow-ups and cases of failed repairs. These studies suggest that the procedure can be performed successfully, but they do not specifically highlight any major safety concerns, indicating it is generally safe for human use.12356
How is the ChEVAS treatment different from other treatments for abdominal aortic aneurysm?
The ChEVAS treatment combines endovascular aneurysm sealing with chimney grafts, making it unique for treating complex abdominal aortic aneurysms, especially when conventional treatments like open repair or fenestrated endovascular repair are not feasible. This approach allows for a suprarenal seal, which is beneficial in challenging cases where other methods may not be suitable.13578
Eligibility Criteria
This trial is for adults over 18 with abdominal aortic aneurysms meeting specific size criteria and without significant vessel angulation. Candidates must consent to follow-up visits, not be in other studies within the last 30 days, have no allergies to materials used, or conditions like Marfan Syndrome that could affect results.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-procedure Imaging
Participants undergo a high resolution, contrast-enhanced CT scan of the relevant aortic and aortoiliac vasculature within three months of the scheduled procedure
Treatment
The ChEVAS procedure involves the use of the Nellix System in conjunction with parallel branch chimney stents for the treatment of abdominal aortic aneurysms
Follow-up
Participants are monitored for safety and effectiveness after treatment with follow-up visits at 30-days, 6-months, and annually to 5-years
Treatment Details
Interventions
- Chimney Endovascular Aortic Sealing (ChEVAS) System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Endologix
Lead Sponsor